Papadopoulou E, Loutradis C, Tzatzagou G, Kotsa K, et al. Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. J Hypertens 2020 Nov 11. doi: 10.1097/HJH.0000000000002690.
PMID: 33186325